The overall sentiment of these big-money traders is split between 36% bullish and 31%, bearish. Out of all of the special options we uncovered, 10 are puts, for a total amount of $724,710, and 12 are ...

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using patents to thwart competition.

Tariff orders released by the White House call for increases in the tariff rate on Canada from 25 percent to 35 percent, ...

26 analysts have shared their evaluations of Regeneron Pharmaceuticals (NASDAQ: REGN) during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you ...

Regeneron will acquire exclusive clinical development and commercial rights for HS-20094, a dual GLP-1/GIP receptor agonist, outside the Chinese Mainland, Hong Kong and Macau.

The saga began early last year when Regeneron filed a lawsuit accusing Amgen of infringing a key patent on its best-selling Eylea injectable drug, which is used to combat such eye diseases as wet ...

South Florida will see a shift in the recent weather pattern into the weekend as a strong ridge of high pressure builds in from the western Atlantic.

The weekend brought heavy rain and flooding to many parts of the Lone Star State, especially parts of North Texas, West Texas and in the Hill Country. Thankfully, a shift in the weather pattern is ...

The market for chronic obstructive pulmonary disease treatment devices is projected to witness substantial growth, fueled by ...

Houston's weather pattern is about to shift. Here's what to expect this week. By Anthony Franze, Newsroom Meteorologist July 20, 2025 ...

The NICL AO Phase 1 exam is all set to be conducted on July 20, 2025. Thousands of aspirants are expected to participate in this online exam, competing for 266 vacancies. With less than 24 hours ...